|
|
Research
Rodent-associated Bartonella Febrile Illness,
Southwestern United States
Jonathan Iralu,* Ying Bai,† Larry
Crook,* Bruce Tempest,* Gary Simpson,‡ Taylor McKenzie,§ and Frederick Koster¶#
*US Public Health Service,
Gallup, New Mexico, USA; †University of Colorado, Boulder, Colorado, USA; ‡New
Mexico Department of Health, Santa Fe, New Mexico, USA; §The Navajo Nation,
Window Rock, AZ, USA; ¶University of New Mexico Health Science Center,
Albuquerque, New Mexico, USA; and #Lovelace Respiratory Research Institute,
Albuquerque, New Mexico, USA
Suggested citation for this
article
Table 2. Clinical and laboratory data of 5 adults with
undifferentiated fever and seroconversion to Neotoma albigula–derived Bartonella antigens* |
|
Patient no., age (y), sex |
DOI |
T
(°C)† |
Leukocytes × 103/μL‡ |
PLT × 103/μL‡ |
HCT
(%)† |
AST
(U/L)† |
BIL
(mg/dL)† |
LDH
(U/L)† |
Doubling
dilution end titer (acute/convalescent phases)§ |
|
Bartonella from Neotoma |
B. vinsonii from Microtus pennsylvanicus |
B. quintana |
B. henselae |
B. elizabethae |
|
1, 55, F |
5 |
39.7 |
2.7 |
147 |
44 |
183 |
1.5 |
167 |
256/4,096 |
64/64 |
<32/64 |
<32/<32 |
64/64 |
2, 30, M |
5 |
39.3 |
3.2 |
110 |
50 |
85 |
1.5 |
206 |
256/1,024 |
128/1,024 |
64/512 |
64/256 |
64/512 |
3, 34, F |
6 |
39.7 |
3.5 |
95 |
44 |
324 |
1.7 |
190 |
<32/1,024 |
<32/256 |
<32/64 |
64/256 |
<32/64 |
4, 29, M |
2 |
39.2 |
17.9 |
226 |
48 |
ND |
ND |
ND |
<32/512 |
32/64 |
<32/<32 |
<32/<32 |
32/32 |
5, 23, F |
2 |
38.8 |
5.0 |
125 |
40 |
ND |
ND |
130 |
32/512 |
<32/64 |
<32/<32 |
<32/128 |
<32/64 |
|
*DOI, day of symptomatic
illness at hospitalization; T, temperature; PLT, platelet count; HCT,
hematocrit ; AST, aspartate aminotransferase; BIL, bilirubin; LDH, lactate
dehydrogenase; ND, not determined. |
†Highest value during 2–6
d of hospitalization. |
‡Minimum value. |
§Convalescent-phase titers
2–6 wk after hospital admission. |
Table 3. Clinical and laboratory data of 4 adults with
undifferentiated fever and a single convalescent-phase titer to Neotoma
albigula–derived Bartonella antigens* |
|
Patient no., age (y), sex |
DOI |
T
(°C)† |
Leukocyte × 103/μL‡ |
PLT × 103/μL‡ |
HCT
(%)† |
AST
(U/L)† |
BIL
(mg/dL)† |
LDH
(U/L)† |
Doubling
dilution end titer (convalescent phase)§ |
|
Bartonella from Neotoma |
B.
vinsonii from Microtus pennsylvanicus |
B.
quintana |
B.
henselae |
B.
elizabethae |
|
6, 42, M |
2 |
39.1 |
23.3 |
11 |
47 |
4,580 |
4.3 |
16,000 |
2,048 |
64 |
<32 |
<64 |
128 |
7, 17, M |
3 |
38.8 |
3.3 |
108 |
43 |
60 |
1.4 |
229 |
1,024 |
256 |
256 |
64 |
512 |
8, 23, F |
3 |
39.0 |
3.9 |
245 |
44 |
834 |
5.2 |
NA |
512 |
256 |
256 |
64 |
64 |
9, 32, M |
7 |
39.0 |
2.9 |
35 |
44 |
1,049 |
3.8 |
1,248 |
512 |
NA |
NA |
NA |
NA |
|
*DOI, day of symptomatic
illness at hospitalization; T, temperature; PLT, platelet count; HCT,
hematocrit; AST, aspartate aminotransferase; BIL, bilirubin; LDH, lactate
dehydrogenase; NA, not available. |
†Highest value during 2–6
d of hospitalization. |
‡Minimum value. |
§Convalescent-phase titers
2–6 wk after hospital admission. |
Suggested citation
for this article:
Iralu J, Bai Y, Crook L, Tempest B, Simpson G, McKenzie T, et al.
Rodent-associated Bartonella febrile illness, southwestern United States. Emerg Infect Dis [serial on the Internet]. 2006 Jul [date cited].
Available from http://www.cdc.gov/ncidod/EID/vol12no07/04-0397.htm
|
